Beate Rohde

1.3k total citations
45 papers, 1000 citations indexed

About

Beate Rohde is a scholar working on Physiology, Psychiatry and Mental health and Reproductive Medicine. According to data from OpenAlex, Beate Rohde has authored 45 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 11 papers in Psychiatry and Mental health and 10 papers in Reproductive Medicine. Recurrent topics in Beate Rohde's work include Alzheimer's disease research and treatments (9 papers), Dementia and Cognitive Impairment Research (9 papers) and Endometriosis Research and Treatment (8 papers). Beate Rohde is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Dementia and Cognitive Impairment Research (9 papers) and Endometriosis Research and Treatment (8 papers). Beate Rohde collaborates with scholars based in Germany, Australia and United States. Beate Rohde's co-authors include Cornelia Reininger, Christopher C. Rowe, Colin L. Masters, Victor L. Villemagne, Kevin Ong, Barbara Pütz, Lueder Fels, Gareth Jones, Rachel S. Mulligan and G. Höll and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and CHEST Journal.

In The Last Decade

Beate Rohde

43 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beate Rohde Germany	16	428	360	226	155	123	45	1000
D. Lang Germany	19	161 0.4×	51 0.1×	84 0.4×	136 0.9×	65 0.5×	54	2.0k
M C Browning United Kingdom	22	174 0.4×	116 0.3×	46 0.2×	124 0.8×	19 0.2×	63	1.4k
K. Liewendahl Finland	22	179 0.4×	142 0.4×	172 0.8×	114 0.7×	39 0.3×	92	1.3k
Hülya Aybek Türkiye	15	80 0.2×	87 0.2×	38 0.2×	59 0.4×	13 0.1×	40	752
Mine Kadıoğlu Türkiye	19	127 0.3×	60 0.2×	25 0.1×	75 0.5×	19 0.2×	49	905
Maria Mirabelli Italy	18	306 0.7×	70 0.2×	33 0.1×	51 0.3×	12 0.1×	49	1.1k
Marie‐Liesse Piketty France	17	69 0.2×	91 0.3×	47 0.2×	41 0.3×	16 0.1×	34	892
Stanley Sau Ching Wong Hong Kong	18	120 0.3×	53 0.1×	27 0.1×	165 1.1×	22 0.2×	64	1.0k
William H. Blahd United States	18	251 0.6×	69 0.2×	176 0.8×	159 1.0×	45 0.4×	60	1.1k

Countries citing papers authored by Beate Rohde

Since Specialization

Citations

This map shows the geographic impact of Beate Rohde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beate Rohde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beate Rohde more than expected).

Fields of papers citing papers by Beate Rohde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beate Rohde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beate Rohde. The network helps show where Beate Rohde may publish in the future.

Co-authorship network of co-authors of Beate Rohde

This figure shows the co-authorship network connecting the top 25 collaborators of Beate Rohde. A scholar is included among the top collaborators of Beate Rohde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beate Rohde. Beate Rohde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baumann, Sybille, Isabella Gashaw, Stefan Klein, et al.. (2025). Safety, Tolerability, and Pharmacokinetics of Filapixant, a Highly Selective P2X3 Receptor Antagonist, in an Ascending-Single-Dose First-in-Human Study. Pharmaceuticals. 18(5). 758–758. 1 indexed citations

Ploeger, Bart A., Andrea Wagenfeld, Herbert Wiesinger, et al.. (2025). Zabedosertib, a novel interleukin-1 receptor-associated kinase-4 inhibitor, shows a favorable pharmacokinetic and safety profile across multiple phase 1 studies. Frontiers in Pharmacology. 16. 1521505–1521505.

Klein, Stefan, Andrea Wagenfeld, Frank S. Zollmann, et al.. (2024). The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers. Clinical and Translational Science. 17(3). e13771–e13771. 9 indexed citations

Wagenfeld, Andrea, et al.. (2018). Exploratory analysis of molecular pharmacodynamic effects of vilaprisan in the endometrium. Fertility and Sterility. 110(4). e134–e135. 1 indexed citations

Nave, R., et al.. (2016). Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial. Human Reproduction. 31(8). 1713–1722. 25 indexed citations

Seitz, Christian, et al.. (2016). Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women. Human Reproduction. 31(8). 1703–1712. 33 indexed citations

Duijkers, Ingrid, et al.. (2015). A two-centre, open-label, randomised study of ovulation inhibition with three transdermal contraceptive patches, each containing different amounts of ethinyl estradiol and gestodene in healthy, young women. Journal of Obstetrics and Gynaecology. 36(1). 106–113. 4 indexed citations

Winkler, Julia, Mark Goldammer, Matthias Ludwig, Beate Rohde, & Christian Zurth. (2014). Pharmacokinetic drug–drug interaction between ethinyl estradiol and gestodene, administered as a transdermal fertility control patch, and two CYP3A4 inhibitors and a CYP3A4 substrate. European Journal of Drug Metabolism and Pharmacokinetics. 40(4). 389–399. 6 indexed citations

Blode, Hartmut, Susanne Parke, Torsten Zimmermann, et al.. (2012). Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal women. Contraception. 86(4). 337–344. 21 indexed citations

10.

Wiesinger, Herbert, Frank Richard, Dietmar Trummer, et al.. (2012). Bioequivalence Evaluation of a Folate-Supplemented Oral Contraceptive Containing Ethinylestradiol/Drospirenone/Levomefolate Calcium versus Ethinylestradiol/Drospirenone and Levomefolate Calcium Alone. Clinical Drug Investigation. 32(10). 673–684. 3 indexed citations

11.

Villemagne, VL, Alex Bahar‐Fuchs, Fiona Lamb, et al.. (2011). CONVERSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER'S DISEASE OVER 12 MONTHS: PREDICTIVE VALUE OF AB IMAGING WITH F-18-FLORBETABEN. Internal Medicine Journal. 41. 1 indexed citations

12.

Barthel, Henryk, Julia Luthardt, Georg Becker, et al.. (2011). Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls. European Journal of Nuclear Medicine and Molecular Imaging. 38(9). 1702–1714. 84 indexed citations

13.

Blode, Hartmut, Christine Klipping, Frank Richard, et al.. (2011). Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone. Contraception. 85(2). 177–184. 5 indexed citations

14.

Villemagne, Victor L., Kevin Ong, Rachel S. Mulligan, et al.. (2011). Amyloid Imaging with¹⁸F-Florbetaben in Alzheimer Disease and Other Dementias. Journal of Nuclear Medicine. 52(8). 1210–1217. 266 indexed citations

15.

Schäfer, Niklaus, Ray Valencia, Sandra Borkowski, et al.. (2011). Abstract 4139: Diagnostic performance of the F-18 labeled bombesin analog BAY 86-4367 in patients with primary prostate cancer. Cancer Research. 71(8_Supplement). 4139–4139. 1 indexed citations

16.

Olschewski, Horst, Beate Rohde, R Ewert, et al.. (2003). Pharmacodynamics and Pharmacokinetics of Inhaled Iloprost, Aerosolized by Three Different Devices, in Severe Pulmonary Hypertension. CHEST Journal. 124(4). 1294–1304. 102 indexed citations

17.

Wacke, R., et al.. (2000). Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics. European Journal of Clinical Pharmacology. 56(1). 43–48. 29 indexed citations

18.

Wacke, R., et al.. (1998). Pharmacokinetic studies of oral and intravenous cyclosporine in prekidney transplant patient. Transplantation Proceedings. 30(5). 1663–1663. 2 indexed citations

19.

Rohde, Beate, et al.. (1997). Pharmacokinetics of mezlocillin and sulbactam under continuous veno-venous hemodialysis (CVVHD) in intensive care patients with acute renal failure. European Journal of Clinical Pharmacology. 53(2). 111–115. 5 indexed citations

20.

Fischer, Ulrike, Beate Rohde, R. Wacke, et al.. (1997). Prediction of In Vivo Drug Interaction from In Vitro Systems Exemplified by Interaction Between Verapamil and Cimetidine Using Human Liver Microsomes and Primary Hepatocytes. The Journal of Clinical Pharmacology. 37(12). 1150–1159. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact